Professor Kamlesh Khunti, FRCGP, FRCP, MD, PhD, FMedSci

Professor of Primary Care Diabetes & Vascular Medicine                                                                    Prof Kamlesh Khunti

Diabetes Research Centre,

University of Leicester, Leicester General Hospital

Gwendolen Road, Leicester, LE5 4PW

Tel: +44 (0)116 258 4005

Email :

General enquiries

Email PA: Raj Gill on

Telephone +44 (0)116 258 4005 or mobile + 44 (0)7496 100973


Professor Kamlesh Khunti is Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester, UK. He is Co-Director of the Leicester Diabetes Centre and leads a research group that is currently working on the early identification of, and interventions with, people who have cardiometabolic disease or are at increased risk of developing cardiometabolic diseases.

His work has influenced national and international guidelines on the screening and management of people with diabetes. Professor Khunti is also Director of the UK National Institute for Health Research (NIHR) in Applied Research Collaborations (ARC) East Midlands and Director of The Real World Evidence Unit and Centre for BME Health. He is a NIHR Senior Investigator and Principal Investigator on several major national and international studies. He is the National NIHR ARC Theme Lead for Multimorbidity and Ethnicity and Diversity. He is also Honorary Visiting Professorial Fellow with Department of General Practice, University of Melbourne.

  • NIHR, Senior Investigator Award - 2014
  • Fellow of Academy of Medical Sciences - 2016
  • Member of the Scientific Advisory Group for Emergency (SAGE)
  • Chair, Ethnicity Subgroup of SAGE
  • Member, Independent SAGE.

Specific Areas of Academic Interest:

  • Cardiometabolic disease
  • Prevention of Diabetes
  • Risk Assessment Tools
  • Black Minority Ethnic Health
  • Real World Evidence
  • Randomised Controlled Trials


You can visit the following page to access my academic publications on COVID-19.

COVID-19 publications


938. Khunti K, Davies MJ, Kosiborod MN, Nauck MA. Long COVID-metabolic risk factors and novel therapeutic management. Nature Reviews Endocrinology 2021 Apr 19. Doi: 10.1038/s41574-021-00495-0.PMID :33875855

937. Versace VL, Beks H, Wesley H, McNamara K, Hague W, Anjana RM, Mohan V, Khunti K, Dunbar JA. Metformin for Preventing Type 2 Diabetes Mellitus in Women with a Previous Diagnosis of Gestational Diabetes: A Narrative Review. Semin Reprod Med 2021 Apr 15. Doi: 10.1055/s-0041-1727203. [Online ahead of print].PMID: 33860488

936. Khunti K, Charbonnel B, Cooper A, Gomes MB, Ji L, Leigh P, Nicolucci A, Rathmann W, Shestakova MV, Siddiqui A, Tang F, Watada H, Chen H; DISCOVER investigators. Associations between second-line glucose-lowering combination therapies with metformin and HbA 1c , body weight, quality of life, hypoglycaemic events, and glucose-lowering treatment intensification: the DISCOVER study. Diabetes Obes Metab 2021 Apr 14. Doi: 10.1111/dom.14400. Online ahead of print. PMID: 33852202

935. Khunti K, Charbonnel B, Chen H, Cherney DZ, Cooper A, Fenici P, Gomes MB, Hammar N, Heerspink HJL, Ji L, Medina J, Nicolucci A, Ramirez L, Rathmann W, Shestakova MV, Shimomura I, Tang F, Watada H, Kosiborod M; DISCOVER Investigators. Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: insights from the DISCOVER study. Diabetes Obes Metab 2021 Apr 14. Doi: 10.1111/dom.14401. [Online ahead of print].PMID: 33852196

934. Nickinson ATO, Coles B, Payne TJ, Davies RSM, Khunti K, Sayers RD. Is Socio-economic Deprivation Associated with One Year Post-operative Mortality Following Major Amputation for Chronic Limb Threatening Ischaemia? Eur J Vasc Endovasc Surg 2021 Apr 10. Doi: 10.1016/j.ejvs.2021.02.020.[ Online ahead of print].PMID: 33849748

933Aschner P, Galstyan G, Yavuz DG, Litwak L, Gonzalez-Galvez G, Goldberg-Eliaschewitz F, Hafidh K, Djaballah K, Tu ST, Unnikrishnan AG, Khunti K. Glycemic control and Prevention of Diabetic Complications in Low- and Middled income countries : An Expert Opinion. Diabetes Ther 2021 Apr 10. Doi: 10.1007/s13300-021-00997-0.[Online ahead of print].PMID: 33840067

932. Ali SN, Hanif W, Patel K, Khunti K. Ramadan and COVID-19 vaccine hesitancy- a call for action. The Lancet 2021 April 7. Doi :10.1016/S0140-6736(21)00779-0. [Online ahead of print]PMID: 33838109

931.  Dambha-Miller H, Tan PS, Saatci D, Clift AK, Zaccardi F, Coupland C, Locufier P, Davies  F, Khunti K, Griffin SJ, Hippisley-Cox J . Quantifying the association between ethnicity and COVID-19 mortality: a national cohort study protocol. BMJ Open 2021 Apr 7;11(4):e045286. Doi: 10.1136/bmjopen-2020-045286.PMID: 33827839

930 Routen A, Darko N, Willis A, Miksza J, Khunti K. It’s so tough for us now” - Covid-19 has negatively impacted religious practices relating to death amongst minority ethnic groups. Public Health 2021 Mar .Doi: 10.1016/j.puhe.2021.03.007

929. Khunti K, Knighton P, Zaccardi F, Bakhai C, Barron E, Holman N, Kar P, Meace C, Sattar N, Sharp S, Wareham NJ, Weaver A, Woch E, Young B, Valabhji J. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol 2021 Mar 30. Doi: 10.1016/S2213-8587(21)00050-4. [Online ahead of print].PMID: 33798464

928.   Argyridou S, Davies MJ, Biddle GJH, Bernieh D, Suzuki T, Dawkins NP, Rowlands AV, Khunti  K, Smith AC, Yates T. Evaluation of an 8-Week Vegan Diet on Plasma Trimethylamine-N-Oxide and Postchallenge Glucose in Adults with Dysglycemia or Obesity. J Nutr 2021 Mar 30. Doi: 10.1093/jn/nxab046. [Online ahead of print].PMID: 33784394

927.    Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, Banerjee   A. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 2021 Mar 31.372:n693. Doi: 10.1136/bmj.n693.PMID: 33789877

926. Biddle SJH, Henson J, Davies MJ, Khunti K, Sutton S, Yates T, Edwardson CL. Device-assessed total and prolonged sitting time: associations with anxiety, depression, and health-related quality of life in adults. J Affect Disord 2021 Mar 19.287:107-114. Doi: 10.1016/j.jad.2021.03.037. [Online ahead of print].PMID: 33774318

925.  Kloecker DE, Davies MJ, Khunti K, Zaccardi F. Cardiovascular effects of SGLT-2 inhibitors and GLP-1 receptor agonists: the P-value and beyond. Diabetes Obes Metab 2021 Mar 25. Doi: 10.1111/dom.14384. [Online ahead of print].PMID: 33764645

924. Nafilyan V, Islam N, Ayoubkhani D, Gilles C, Katikireddi SV, Mathur R, Summerfield A, Tingay K, Asaria M, John A, Goldblatt P, Banerjee A, Glickman M, Khunti K. Ethnicity, household composition and COVID-19 mortality: a national linked data study. J R Soc Med 2021 Mar 24:141076821999973. Doi: 10.1177/0141076821999973. [Online ahead of print].PMID: 33759630

923. Yates T, Zaccardi F, Islam N, Razieh C, Gillies CL, Lawson CA, Chudasama Y, Rowlands A, Davies MJ, Docherty AB, Openshaw PJ, Baillie JK, Semple MG; ISARIC4C investigators, Khunti K. Obesity, ethnicity and risk of critical care, mechanical ventilation and mortality in patients admitted to hospital with COVID-19: Analysis of the ISARIC CCP-UK cohort. Obesity (Silver Spring) 2021 Mar 23. Doi: 10.1002/oby.23178. [Online ahead of print].PMID: 33755331

922Pan D, Sze S, Martin CA, Nevill CR, Minhas JS, Divall P, Nazareth J, Gray LJ, Khunti K, Abrams KR, Nellums LB, Pareek M.. COVID-19 and the new variant strain in England-what are the implications for those from ethnic minority group. EClinicalMedicine 2021 Mar; 33:100805. Doi: 10.1016/j.eclinm.2021.100805. [Epub 2021 Mar 18]. PMID: 33754139

921. Razieh C, Zaccardi F, Islam N, Gillies CL, Chudasama Y, Rowlands A, Kloecker DE, Davies MJ, Khunti K, Yates T. Ethnic minorities and COVID-19. : Examining whether excess risk is mediated through deprivation. Eur J Public Health 2021 Mar 21.Doi: 10.1093/eurpub/ckab041. [Online ahead of print].PMID: 33744940

920.  Khunti K, Griffiths A, Majeed A, Nagpaul C, Rao M. Assessing risk for healthcare workers during pandemic. BMJ 2021 Mar 15; 372: n602. Doi: 10.1136/bmj.n602. PMID: 33722904

919. Usman M, Khunti K, Davies MJ, Gillies CL. Association and relative importance of multiple risk factor control on cardiovascular disease, end-stage renal disease and mortality in people with type 2 diabetes: A population-based retrospective cohort study. Primary Care Diabetes 2021 Apr.15 (2):218-226. DOI: 10.1016/j.pcd.2020.08.008. [Epub 2020 Aug 27]. PMID: 32863149

918 Navaneethan SD, Zoungas S, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Liew A, Michos ED, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wanner C, Wilkens KG, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli M, Cheung M, Earley A, Rossing P, de Boer IH, Khunti K. Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline. Ann Intern Med 2021 Mar.174 (3):385-394. Doi: 10.7326/M20-5938. [Epub 2020 Nov 10].PMID: 33166222

917. Hadjiconstantinou M, Barker MM, Brough C, Schreder S, Northern A, Stribling B, Khunti K, Davies MJ. Improved diabetes-related distress and self-efficacy outcomes in a self-management digital programme for people with type 2 diabetes, MyDESMOND. Diabetic Medicine 2021 Mar 6:e14551. Doi: 10.1111/dme.14551. [Online ahead of print].PMID: 33675068

916.  Vimaleswaran KS, Forouhi NG, Khunti K. Vitamin D and Covid-19. BMJ 2021 Mar 4;372:n544. Doi: 10.1136/bmj.n544. PMID: 33664083

915. Pratley RE, Crowley MJ, Gislum M, Hertz CL, Jensen TB, Khunti K, Mosenzon O, Buse JB. Oral Semaglutide Reduces HbA 1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses. Diabetes Therapy 2021 apr 12(4):1099-11. Doi: 10.1007/s13300-020-00994-9. [Epub 2021 Mar 4].PMID: 33660198

914. Minhas JS, Coles B, Khunti K. Robinson TG. Blood pressure and outcome in patients with atrial fibrillation: floating in unchartered waters Reply. Journal of Hypertension 2021 Mar. 39(3):1 Doi: 10.1097/HJH.0000000000002740. PMID: 33543887

913. Ling JZJ, Montvida O, Khunti K, Zhang AL, Xue CC, Paul SK. Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: a real-world evidence from primary care. Diabetes Obes Metab 2021 Apr 44(4):915-924.Doi: 10.1111/dom.14364. [Epub 2021 Feb 4].PMID: 33651456

912 Rowlands AV, Henson JJ, Coull NA, Edwardson CL, Brady E, Hall A, Khunti K, Davies M, Yates T. The impact of COVID-19 restrictions on accelerometer-assessed physical activity and sleep in individuals with type 2 diabetes. Diabet Medicine 2021 Mar 1:e14549. Doi: 10.1111/dme.14549. [Online ahead of print].PMID: 33650112

911. Strelitz J, Sharp SJ, Khunti K, Vos RC, Rutten GE, Webb DR, Witte DR, Sandbaek A, Wareham NJ, Griffin SJ. Association of weight loss and weight loss maintenance following diabetes diagnosis by screening and incidence of cardiovascular disease and all-cause mortality: an observational analysis of the ADDITION-Europe trial. Diabetes Obes Metab 2021 Mar. 23(3):730-741. Doi: 10.1111/dom.14278.[Epub 2020 Dec 21].PMID: 33269535

910. Quinn LM, Davies MJ, Northern A, Brough C, Schreder S, Stribling B, Khunti K, Hadjiconstantinou M. Use of MyDesmond digital education programme to support self-management in people with type 2 diabetes during the COVID-19 pandemic. Diabetic Medicine 2021 Mar. 38(3):e14469. Doi: 10.1111/dme.14469. [Epub 2020 Dec 23]. PMID: 33274489

909. Jones P, Davies MJ, Khunti K, Fong DTP, Webb D. In-shoe pressure thresholds for people with diabetes and neuropathy at risk of ulceration: A systematic review. J Diabetes Complications 2021 Mar.35 (3):107815.Doi: 10.1016/j.jdiacomp.2020.107815.[Epub 2020 Nov 26].PMID: 33280984

908. Bornstein SR, Rubino F, Ludwig B, Rietzsch H, Schwarz PEH, Rodionov RN, Khunti K, Hopkins D, Birkenfeld AL, Boehm B, Amiel S, Holt RIG, Skyler JS, DeVries JH, Renard E, Eckel RH, Zimmet P, Alberti KG, Geloneze B, Chan JC, Mbanya JC, Onyegbutulem HC, Ramachandran A, Basit A, Hassanein M, Spinas GA, Beuschlein F, Mingrone G. Consequences of the COVID-19 pandemic for patients with metabolic diseases. Nature Metabolism 2021 Mar 3(3):289-292. Doi: 10.1038/s42255-021-00358-y. PMID: 33633407

907. Yates T, Razieh C, Zaccardi F, Rowlands AV, Seidu S, Davies MJ, Khunti K. Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank. Int J Obes (Lond) 2021 Feb 26.11(1):4787. Doi: 10.1038/s41366-021-00771-z.PMID: 33637952

906Coles B, Tyrer F, Hussein H, Dhalwani N, Khunti K. Development ,content validation and reliability of the Assessment of Real World Observational Studies(ArRoWS) critical appraisal tool. Annals of Epidemiology 2021 Mar.55:57-63:e15.Doi: 10.1016/j.annepidem.2020.09.014. [Epub 2020 Oct 1]. PMID: 33011384

905. Ekezie W, Routen A, Denegri S, Khunti K. Patient and public involvement for ethnic minority research : an urgent need for improvement. J R Soc Med 2021 Feb 24. Doi: 10.1177/0141076821994274. [Online ahead of print]. PMID: 33625873

904. Banerjee A, Chen S, Pasea L, Lai AG, Katsoulis M, Denaxas S, Nafilyan V, Williams B, Wong WK, Bakhai A, Khunti K, Pillay D, Noursadeghi M, Wu H, Pareek N, Bromage D, McDonagh TA, Byrne J, Teo JTH, Shah AM, Humberstone B, Tang LV, Shah ASV, Rubboli A, Guo Y, Hu Y, Sudlow CLM, Lip GYH, Hemingway H. Excess deaths in people with cardiovascular diseases during Covid-19 pandemic. Eur J Prev Cardiol 2021 Feb 21:. 5. Doi: 10.1093/eurjpc/zwaa155. [Online ahead of print].PMID: 33611594

903. Zaccardi F, Kloecker DE, Davies MJ, Khunti K. Using observational data to prioritise COVID-19 vaccination strategies : opportunity or necessity? Public Health 2021 Feb. Doi: 10.1016/j.puhe.2021.01.020 [Epub ahead of print].PMID: 33691934

902. Arnold SV, Khunti K, Bonnet F, Charbonnel B, Chen H, Cid-Ruzafa J, Cooper A, Fenici P, Gomes MB, Hammar N, Ji L, Luporini-Saraiva G, Medina J, Nicolucci A, Ramirez L, Shestakova MV, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Kosiborod M; DISCOVER investigators. Type 2 Diabetes and heart failure: insights from the global DISCOVER study. ESC Heart Fail 2021 Feb 11. Doi: 10.1002/ehf2.13235. [Online ahead of print].PMID: 33570253

901 Ahmad E, Waller HL, Sargeant JA, Webb MA, Htike ZZ, McCann GP, Gulsin G, Khunti K,Yates T, Henson J, Davies MJ, Webb DR. Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity: Analyses from the LYDIA trial. Diabetes Obes Metab 2021 Feb 10. Doi: 10.1111/dom.14343. [Online ahead of print]. PMID: 33565691

900. Wang J, Cooper JM, Gokhale K, Acosta-Mena D, Dhalla S, Byne N, Chandan JS, Anand A,  Okoth K, Subramanian A, Bangash MN, Jackson T, Zemedikun D, Taverner T, Hanif W, Ghosh S, Narendran P, Toulis K, Tahrani A, Surenthirakumaran R, Adderley NJ, Haroon S, Khunti K, Sainsbury C, Thomas GN, Nirantharakumar K. Association of metformin with susceptibility to COVID-19 in people with type 2 diabetes. J Clin Endocrinol Metab 2021 Feb 9. Doi: 10.1210/clinem/dgab067. [Online ahead of print].PMID: 33560344

899Hadjiconstantinou M, Quinn LM, Tippins F, Schreder S, Khunti K, Davies MJ . A perspective piece on Diabetes Self-Management Education and Support (DSMES) programmes for under-represented groups with T2DM in the UK. British Journal of Diabetes 2021 Mar. Doi: 10.15277/bjd.2021.278. [Online ahead of print].

898. Coles B, Zaccardi F, Seidu S, Gillies CL, Davies MJ, Hvid C, Khunti K. Rates and estimated cost of primary care consultations in people diagnosed with type 2 diabetes and comorbidities: A retrospective analysis of 8.9 million consultations. Diabetes, Obesity and Metabolism 2021 Feb 4. Doi: 10.1111/dom.14340. [Online ahead of print].PMID: 33539642

897. Ling S, Zaccardi F, Lawson C, Seidu SI, Davies MJ, Khunti K. Glucose control, Sulfonylureas, and Insulin Treatment in Elderly people with type 2 Diabetes and Risk of Severe Hypoglycemia and Death: An observational study. Diabetes Care 2021 Feb. Doi: 10.2337/dc20-0876.[Online ahead of print]. PMID:33541857

896. Lawson CA, Seidu S, Zaccardi F, McCann G, Kadam UT, Davies MJ, Lam SPC,  Heerspink   HL, Khunti K. Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over 20 years. Eclinical Medicine 2021 Feb. 4(32):100739.Doi: 10.1016/j.eclinm.2021.100739. [eCollection Feb 2021t] PMID :33688855.

895. Herring LY, Dallosso H, Schreder S, Smith EJ, Waheed G, Gray LJ, Khunti K, Yates T, Highton PJ, Rowlands AV, Hudson I, Seidu S, Davies MJ. Physical Activity after Cardiac EventS (PACES): a group education programme with subsequent text message support designed to increase physical activity in individuals with diagnosed coronary heart disease: a randomised controlled trial. Open Heart 2021 Feb. 8(1) : e001351. Doi: 10.1136/openhrt-2020-001351.PMID: 33637567

894. Zaccardi F, Kloecker DE, Buse JB, Mathieu C, Khunti K, Davies MJ. Use of Metformin and Cardiovascular Effects of Glucose Lowering Agents: A Meta-analysis of Cardiovascular outcome trials in Type 2 Diabetes. Diabetes Care 2021 Feb. 44(2): e32-e34. Doi: 10.2337/dc20-2080. [Epub 2020 Dec 17]. PMID: 33334809

893. Khunti K. SGLT2 inhibitors in people with and without T2DM. Nature Review Endocrinology 2021 Feb 17(2): 75-76. Doi: 10.1038/s41574-020-00453-2.PMID: 33293703

892. Inzucchi SE, Davies MJ, Khunti K, Trivedi P, George JT, Zwiener I, Johansen OE, Sattar N. Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes. Diabetes Obesity and Metabolism 2021 Feb. 23(2):425-433. Doi: 10.1111/dom.14234. [Epub 2020 Nov 20].PMID: 33084149

891. Seidu S, Mellbin L, Kaiser M, Khunti K. Will oral semaglutide be a game-changer in the  management of type 2 diabetes in primary care? Primary Care Diabetes 2021 Feb. 15(1):59-68. DOI: 10.1016/j.pcd.2020.07.011 [Epub 2020 Aug 19]. PMID: 32826189

890. Hanif W, Ali S, Bellary S, Patel V, Farooqi A, Karamat MA, Saeed M, Sivaprasad S, Patel K, Khunti K. Pharmacological management of South Asians with Type 2 Diabetes: Consensus Recommendations from the South Asian Health Foundation. Diabetic Medicine 2021 Apr. 38(4):e14497.Doi: 10.1111/dme.14497. [Epub 2021 Feb 11].PMID:33301625

889. Farooqi AT, Snoek FJ, Khunti K. Management of chronic cardiometabolic conditions and mental health during COVID-19. Primary Care Diabetes 2021 Feb. 5(1):21-23. DOI: 10.1016/j.pcd.2020.08.016. [Epub 2020 Sep 8].PMID: 32917554

889. Seidu S, Cos X, Brunton S, Harris SB, Jansson SPO, Mata-Cases M, Neijens AMJ, Topsever P, Khunti K. A disease state approach to the pharmacological management of Type 2 diabetes in primary care. A position statement by Primary Care Diabetes Europe. Primary care Diabetes 2021 Feb.15 (1):31-51. DOI: 10.1016/j.pcd.2020.05.004. [Epub 2020 Jun 10].PMID: 32532635

888. Pan D, Sze S, Martin CA, Nevill CR, Divall P, Nazareth J, Gray LJ, Khunti K, Abrams KR, Nellums LB, Pareek M. The missing link in ethnicity and covid-19 research- time to separate the risk of infection from the risk of severe disease. BMJ 2021 Jan 29.

887. Morriss R, Tyrer F, Zaccardi F, Khunti K. Safety of antidepressants in a primary care  cohort of  adults with obesity and depression. PLoS One 2021 Jan 29;16(1):e0245722. Doi: 10.1371/journal.pone.0245722. eCollection 2021.PMID: 33513174

886.Highton PJ, Mistri A, Ng A, Glover K, Khunti K, Seidu S. Evaluating the use of a mobile  device for detection of atrial fibrillation in primary care. British Journal of Cardiology 2021 Jan. 28(1). Doi : 10.5837/bjc.2021.005 [online ahead of print].

885. Harrington DM, Brady EM, Weihrauch-Bluher S, Edwardson CL, Gray LJ, Hadjiconstantinou M,   Jarvis J, Khunti K, Vergara I, Erreguerena I, Ribeiro RT, Troughton J, Vazeou A, Davies MJ. Development of an Interactive Lifestyle Programme for Adolescents at Risk of Developing Type 2 Diabetes: PRE-STARt. Children (Basel) 2021 Jan .21;8(2):69. Doi: 10.3390/children8020069. PMID: 33494347

884 Ling J, Koye D, Buizen L, Khunti K, Montvida O, Paul SK. Temporal Trends in Comorbidities and Cardiometabolic Risk Factors at the Time of Diagnosis of Type 2 Diabetes in UK. Diabetes Obes Metab 2021 Jan 26. Doi: 10.1111/dom.14323. [Online ahead of print].PMID: 33496366

883. Khunti K, Zaccardi F, Islam N. Yates T. Uses and abuses of real-world data in generating evidence during a pandemic. J R Soc Med. 2021 Mar.114(3):109-110. Doi: 10.1177/0141076820985282. [Epub 2021 Jan 18  ]. PMID: 33460335

882. Levene LS, Coles BD, Gillies CL, Shabnam S, Zaccardi F, Khunti K. Predictors of hypertension detection in English general practices : a cross sectional  study. J Public Health (Oxf) 2021 Jan 13. Doi: 10.1093/pubmed/fdaa224. [Online ahead of print] .PMID: 33434926

881. Dawkins NP, Yates T, Edwardson CL, Maylor B, Davies MJ, Dunstan D, Highton PJ, Herring LY, Khunti K, Rowlands AV Comparing 24h physical activity profiles :office workers, women with a history of gestational diabetes and people with chronic disease condition(s). Journal of Sports Sciences 2021 Jan.39 (2):219-226. DOI:  10.1080/02640414.2020.1812202.[Epub 2020 Aug 25]. PMID: 3

880. Coles B,  Zaccardi F, Hvid C, Davies MJ, Khunti K. Cardiovascular events and mortality in people with type 2 diabetes and multimorbidity: a real world study of patients followed up to 19 years. Diabetes, Obesity & Metabolism 2021 Jan.23(1): 218-227. Doi: 10.1111/dom.14218.[Epub 2020 Oct 22].PMID: 33026165

879. Patel KK, Gomes MB, Charbonnel B, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Ji L,  Kennedy KF, Khunti K, Kosiborod M, Pocock S, Shestakova M, Shimomura I, Surmont F, Watada H, Arnold SV. Global Patterns of Comprehensive Cardiovascular Risk Factor Control in Patients with type 2 Diabetes Mellitus: Insights from the DISCOVER Study. Diabetes, obesity and metabolism 2021 Jan.23 (1):39-48. DOI: 10.1111/dom.14180. [Epub 2020 Sep 22].PMID: 32845558

878. Dibato JE, Montvida O, Zaccardi F, Sargeant JA, Davies MJ, Khunti K, Paul SK. Association of Cardiometabolic Multimorbidity and Depression With Cardiovascular Events in Early-Onset Adult Type 2 Diabetes : A Multiethnic Study in the U.S. Diabetes Care 2021 Jan.44(1):231-239. Doi: 10.2337/dc20-2045. [Epub 2020 Nov 11].PMID: 33177170

877. Sargeant JA, Jelleyman C, Coull NA, Edwardson CL, Henson J, King JA, Khunti K, McCarthy M, Rowlands AV, Stensel DJ, Waller HL, Webb DR, Davies MJ, Yates T. Improvements in Glycaemic Control After Acute Moderate-Intensity Continuous or High-Intensity Interval Exercise Are greater in South Asians than White Europeans with Nondiabetic Hyperglycaemia: A Randomized Crossover Study. Diabetes Care 2021 Jan. 44(1):201-209. Doi: 10.2337/dc20-1393. [Epub 2020 Nov 6].PMID: 33158948

876. Rowlands AV, Kloecker DE, Chudasama Y, Davies MJ, Dawkins NP, Edwardson CL, Gillies C, Khunti K, Razieh C, Islam N, Zaccardi F, Yates T. Association of Timing and Balance of Physical Activity and Rest/Sleep with risk of COVID-19: A UK Biobank study. Mayo Clinical Proceedings 2021 Jan .96(1):156-164.Doi: 10.1016/j.mayocp.2020.10.032. PMID : 33413813.

875. Ayoubkhani D, Nafilyan V, White C, Goldblatt P, Gaughan C, Blackwell L, Rogers N, Banerjee A, Khunti K, Glickman M, Humberstone B, Diamond I. Ethnic-minority groups in England and Wales-factors associated with the size and timing of elevated COVID-19 mortality: a retrospective cohort study linking census and death records. Int J Epidemiol 2021 Jan 23.49(6): 1951-1962. Doi: 10.1093/ije/dyaa208. PMID: 33349855

874.  Ling S, Brown K, Miksza J, Howells ML, Morrison A, Issa E, Yates T, Khunti K, Davies MJ,  Zaccardi F. Risk of cancer incidence and mortality associated with diabetes: A systematic review with trend analysis of 203 cohorts. Nutrition, Metabolism & Cardiovascular Disease 2021 Jan 4; 31(1):14-22. Doi: 10.1016/j.numecd.2020.09.023 [Epub 2020 Sep 25]. PMID : 33223399

873.   Vlacho B, Mundet-Tudurí X, Mata-Cases M, Antoni Vallès-Callol J, Real J, Farré M, Cos X, Khunti K, Mauricio D, Franch-Nadal J. Analysis of the effectiveness of second oral glucose-lowering therapy in routine clinical practice from the Mediterranean area: A retrospective cohort study. Diabetes Res Clin Pract 2021 Jan.171:1086106. Doi: 10.1016/j.diabres.2020.108616. [Epub 2020 Dec 10].PMID: 33310172

2020 publications

2019 publications

You can also view  my 2015-2018 publications on Pubmed


2020- European Association for the study of Diabetes 55th annual meeting, ELECTR NETWOR 21-25 September 2020(11 abstracts published in Diabetologia )

2020 - American Diabetes Association’s 80th Scientific Session 12-16 June 2020, Virtual meeting (1 abstract published in Diabetes)

2019 - International Diabetes Federation (IDF) World Diabetes Congress 2019, BEXCO, Busan, Korea, 2-6th December 2019 (2 abstracts published)

2019  - European Association for the study of Diabetes 55th annual meeting, Barcelona, Spain, 16-20 September 2019(9 abstracts published in Diabetologia)

2019 - American Diabetes Association’s 79th Scientific Session 7-11 June, San Francisco, California (9 abstracts published in Diabetes)

2019 - Diabetes UK Professional Conference 2019, 6-8 March 2019, ACC Liverpool. (6 abstracts published).

2018 - ISPOR Europe 2018, 10-14 November, Barcelona, Spain (1 abstract published)

2018 - American Diabetes Association, 78th Scientific Session, 22-26 June, Orlando (6 abstracts published in Diabetes)

2018 - Diabetes UK Professional Conference, 14-16 March, London (5 abstracts published in Diabetic Medicine)

2017 - IDF Congress 2017, Abu Dhabi UAE, 4-8 December 2017 (4 abstracts published on their website)

2017 - 53rd EASD Annual meeting, Lisbon, Portugal, 11-15 September 2017 (11 abstracts published in Diabetologia)

2017 - American Diabetes Association, 77th Scientific Session, June 9-13, 2017 San Diego (8 abstracts published in Diabetes)

2017 - Diabetes UK Professional Conference, 8-10 March 2017, Manchester (3 abstracts published in Diabetic Medicine)

2016 - 11th IDF-WPR Congress 2016 & 8th AASD Scientific Meeting 27-30 October 2016, Taiwan (1 abstract published in Diabetes Research and Clinical Practice)

2016 - Congress of the European Society of Cardiology, 27-31 August, Rome, Italy. (1 abstract published in European Heart Journal)

2016 - 52nd EASD Annual Meeting, Munich, Germany, 12th – 16th September 2016 (4 abstracts published)

2016 - American Diabetes Association (ADA) 76th Scientific Session, New Orleans, USA, 10th -14th June 2016 (7 abstracts published in Diabetes)

2016 - Diabetes UK Professional Conference, Scottish Exhibition and Conference Centre, Glasgow, 2-4 March 2016 (8 abstracts published in Diabetic Medicine)

2016 - 9th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), Milan, Italy, February 3rd – 6th 2016. (2 abstracts published in Diabetes Technology & Therapeutics)

2015 - IDF 2015 World Diabetes Congress, Vancouver, 30th Nov-4th Dec 2015, (9 abstracts accepted and published online)

2015 - 3rd International Clinical Trials Methodology Conference Glasgow, UK. 16-17 November 2015. (1 abstract published in Trials)

2015 - The American Heart Association’s 2015 Scientific Sessions and Resuscitation Science Symposium November 10th 2015 (1 abstract published in Circulation)

2015 - ISPOR 18th Annual European Congress, Milan, 7th-11th November 2015, (2 abstracts accepted and published in Value of Health)

2015 - 51st EASD Annual Meeting, Stockholm, Sweden, 14-18 September 2015, (6 abstracts published in Diabetologia)

2015 - 75th Scientific Sessions of the American Diabetes Association, 5-9 June, Boston, USA. (4 abstracts published in Diabetes)

2015 - 15th International Conference on Integrated Care, Edinburgh, UK, March 25th – 27th, 2015 (1 abstract published in International Journal of Integrated Care)

2015 - Diabetes UK Annual Professional Conference, March, London (13 abstracts published in Diabetic Medicine)

2015 - American Diabetes Association (ADA) 75th Scientific Session, March, Boston, USA (4 abstracts published in Diabetes)


    Professional interest in quality improvement, especially in cardiovascular disease and diabetes, and in teaching

    Interest in evidence-based medicine and audit

    Interest in cardiovascular medicine and diabetes


Current PhD students

Danielli Mariana, March 2020

Role of perivascular biomarkers at the fetal-maternal interface in pre-eclampsia and fetal growth restriction.

Dan Lane, September 2018

Developments of biochemical methods to diagnose non-adherence in cardiometabolic diseases and their clinical utility

Elpida Vounzoulaki September 2018

Type 2 diabetes in women after a diagnosis of gestational diabetes: understanding uptake to screening, progression rates and costs, using evidence synthesis methodologies

Humaira Hussein September 2017

Comparative effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus: randomized and real-word evidence

Back To Top

Share this page: